Laurent DECORY
COVID-19 to reshape R&D investments toward infectious diseases
Infectious diseases have been largely forgotten by Pharma R&D and investors, as chronic diseases, cancer and rare diseases gave better...
top of page
For Pharma, Biotech, MedTech.
Commercialization: Implemented
Search
Laurent DECORY
Dec 13, 20201 min read
Post Brexit, will UK MedTech take back control or align with key markets ?
While Brexit goal is officially to "take back control", UK MedTech may have to choose between aligning regulatory process with EU or US....
0 views0 comments
Laurent DECORY
Dec 12, 20201 min read
Germany bets on its Biotechs and mRNA COVID-19 vaccines
After granting €252M to CureVac, the German government has awarded €375M to BioNTech. BioNtech announcement: https://lnkd.in/dKinEe4...
2 views0 comments
Laurent DECORY
Dec 12, 20201 min read
GENFIT moves focus to promising NASH diagnostic
In a promising but risky NASH market, study shows GENFIT NIS4 easy test allows to identify patients who require treatment, without need...
0 views0 comments
Laurent DECORY
Dec 12, 20201 min read
Biosimilars finally taking off in the US
Usage of Biosimilars has increased significantly in Europe, while usage in the US has been lagging behind. Now, Biosimilars are finally...
0 views0 comments
Laurent DECORY
Dec 12, 20201 min read
UCB’s Bimekizumab to reshape psoriasis market
The $ 20+ billion Psoriasis treatment market has been dominated by AbbVie's Humira. But things might change soon. After beating J&J’s...
5 views0 comments
bottom of page